About
About Brooks Laboratories Limited
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections. It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries. In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Visit company website
5 years, 5 months ago
Brooks Laboratories Limited is currently in a long term uptrend where the price is trading 18.7% above its 200 day moving average.
From a valuation standpoint, the stock is 64.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Brooks Laboratories Limited's total revenue rose by 5.2% to $209M since the same quarter in the previous year.
Its net income has increased by 9.0% to $-26M since the same quarter in the previous year.
Finally, its free cash flow fell by 56.5% to $6M since the same quarter in the previous year.
Based on the above factors, Brooks Laboratories Limited gets an overall score of 4/5.